Alex Lee Ballou, LPN | |
3169 Second Ave E, Bis Stone Gap, VA 24219 | |
(276) 523-8300 | |
(276) 523-6964 |
Full Name | Alex Lee Ballou |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 3169 Second Ave E, Bis Stone Gap, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275671554 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 0002059856 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alex Lee Ballou, LPN Po Box 9054, Gray, TN 37615-9054 Ph: (423) 467-3600 | Alex Lee Ballou, LPN 3169 Second Ave E, Bis Stone Gap, VA 24219 Ph: (276) 523-8300 |
News Archive
Hops, those little cone-shaped buds that give beer its bitter flavor, pack a surprisingly healthful punch. They are widely studied for their ability to halt bacterial growth and disease. Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab. This advance could one day help scientists create medicines from these compounds without having to extract them from plants.
A new review of the emerging variants of concern (VOCs) of the SARS-CoV-2, which has caused the COVID-19 pandemic, shows that there is a major need to constantly re-evaluate the utility of existing therapeutics and vaccines against the virus and to develop new ones.
Patients and family members are either neutral or uncomfortable with the idea of "overlapping" or "concurrent" surgery, where the attending surgeon isn't present in the operating room for part of the procedure, according to survey results published in the November 15, 2017 issue of The Journal of Bone & Joint Surgery. The journal is published in partnership with Wolters Kluwer.
A medical revolution emerges when technology blends with smart care.
In a new study in patients with osteoarthritis (OA) of the knee, at 12 months, total femorotibial cartilage thickness loss was reduced in sprifermin (recombinant human fibroblast growth factor 18)-treated knees compared to placebo-treated knees, with effects being significant in the lateral femorotibial compartment but not in the central femorotibial compartment.
› Verified 4 days ago